Evidence map›Paper›PMID 33320672›Full record

ArticleThe journal of physical chemistry. B2020

Ancillary Ligand in Ternary Cu

Rodrigo Galindo-Murillo, Lauren Winkler, Juan Carlos García-Ramos, Lena Ruiz-Azuara, Fernando Cortés-Guzmán, Thomas E Cheatham

Open access · hybridAbstract read
In one paragraph

Article in The journal of physical chemistry. B, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Rodrigo Galindo-MurilloDepartment of Medicinal Chemistry, College of Pharmacy, University of Utah, 2000 East 30 South Skaggs 306, Salt Lake City, Utah 84112, United States.ORCID 0000-0001-5847-4143
Lauren WinklerDepartment of Medicinal Chemistry, College of Pharmacy, University of Utah, 2000 East 30 South Skaggs 306, Salt Lake City, Utah 84112, United States.
Juan Carlos García-RamosEscuela de Ciencias de la Salud, Universidad Autónoma de Baja California, Blvd. Zertuche y Blvd. Los Lagos, Fraccionamiento Valle Dorado, Ensenada, Baja California 22890, Mexico.ORCID 0000-0001-9861-2467
Lena Ruiz-AzuaraDepartamento de Química Inorgánica y Nuclear. Facultad de Química. Universidad Nacional Autónoma de México. Avenida Universidad 3000, Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0003-3035-4507
Fernando Cortés-GuzmánDepartamento de Fisicoquímica. Instituto de Química. Universidad Nacional Autónoma de México. Avenida Universidad 3000, Ciudad Universitaria, Ciudad de México 04510, Mexico.ORCID 0000-0002-6716-1621
Thomas E CheathamDepartment of Medicinal Chemistry, College of Pharmacy, University of Utah, 2000 East 30 South Skaggs 306, Salt Lake City, Utah 84112, United States.ORCID 0000-0003-0298-3904
University of Utah · USUniversidad Nacional Autónoma de México · MXUniversidad Autónoma de Baja California · MX

Funding

Biomolecular simulation for the end-stage refinement of nucleic acid structureR01GM081411 · NIGMS · UNIVERSITY OF UTAH · PI CHEATHAM, THOMAS E. · 2008 to 2022
$2.7M
NIGMS NIH HHS R01 GM081411
6 · The paper itself

Abstract

Copper-containing compounds known as Casiopeı́nas are biologically active molecules which show promising antineoplastic effects against several cancer types. Two possible hypotheses regarding the mode of action of the Casiopeı́nas have emerged from the experimental evidence: the generation of reactive oxygen species or the ability of the compounds to bind and interact with nucleic acids. Using robust molecular dynamics simulations, we investigate the interaction of four different Casiopeı́nas with the DNA duplex d(GCACGAACGAACGAACGC). The studied copper complexes contain either 4-7- or 5-6-substituted dimethyl phenanthroline as the primary ligand and either glycinate or acetylacetonate as the secondary ligand. For statistical significance and to reduce bias in the simulations, four molecules of each copper compound were manually placed at a distance of 10 Å away from the DNA and 20 independent molecular dynamics simulations were performed, each reaching at least 30 μs. This time scale allows us to reproduce expected DNA terminal base-pair fraying and also to observe intercalation/base-pair eversion events generated by the compounds interacting with DNA. The results reveal that the secondary ligand is the guide toward the mode of binding between the copper complex and DNA in which glycinate prefers minor-groove binding and acetylacetonate produces base-pair eversion and intercalation. The Cu

Indexed as

CopperDNABase PairingLigandsMolecular StructureCopperDNALigands

Identifiers

PMID33320672
PMCPMC7770820
OpenAlexW3112741522

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.